✦ LIBER ✦

Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 1: Infliximab and Adalimumab

✍ Scribed by B. Díaz-Ley; G. Guhl; J. Fernández-Herrera

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Off-Label Use of Biologic Agents in the

✍ G. Guhl; B. Díaz-Ley; J. Fernández-Herrera 📂 Article 📅 2008 🏛 Elsevier Science 🌐 Spanish ⚖ 579 KB

Off-label uses of biologics in dermatolo

✍ Julia E. Graves; Kara Nunley; Michael P. Heffernan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Off-label uses of biologics in dermatolo

✍ David I. Smith; Pooja M. Swamy; Michael P. Heffernan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 526 KB

Oc016—Off-Label Use And Adverse Events O

✍ Broe, J.; Platz, M.A.; Nielsen, S.; Christensen, H.R.; Holst, H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PPN14 OFF-LABEL OPIOID USE IN THE TREATM

✍ W Wright; AS Gilmore; AP Legorreta 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Intermittent Treatment Regimens and the

✍ D. Moreno-Ramírez 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Spanish ⚖ 436 KB